![Tomas L. Lindahl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Tomas L.
Lindahl founded Diapensia HB in 1992, where he is working as Chief Executive Officer from 1992.
Mr. Lindahl also currently works at Nordic Haemostasis AB, as Chairman and MediRox AB, as Independent Director from 2014.
Tomas L. Lindahl active positions
| Companies | Position | Start |
|---|---|---|
| MEDIROX AB | Director/Board Member | 31/07/2014 |
Diapensia HB | Chief Executive Officer | 31/12/1991 |
Nordic Haemostasis AB | Chairman | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
MediRox AB
 MediRox AB Pharmaceuticals: MajorHealth Technology Develops and markets products for the laboratory diagnosis of circulatory disorders | Health Technology |
Diapensia HB | |
Nordic Haemostasis AB |
- Stock Market
- Insiders
- Tomas L. Lindahl
